Suchergebnisse - "Zhu, Feng-Cai"

PubPharm (82)

1

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China : a randomised blinded clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Zhu, F. | Zhong, G. | Huang, W. | +21

CommentIn: Lancet Infect Dis. 2023 Nov;23(11):1215-1216. - PMID 37475117

2

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults : a multicentre, open-label phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Li, J. | Hou, L. | Gou, J. | +23

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1099-1100. - PMID 37352881

3

Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials

enthalten in: The Journal of infectious diseases | 2023

von Xia, X. | Tan, Z. | Wan, P. | +11

4

Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years : a randomised, double-blind, phase 2b trial

enthalten in: The Lancet. Infectious diseases | 2023

von Wu, J. | Li, J. | Liu, J. | +19

CommentIn: Lancet Infect Dis. 2023 Sep;23(9):986-987. - PMID 37216959

5

Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19

enthalten in: Human vaccines & immunotherapeutics | 2023

von Feng, J. | Wang, W. | Jin, P. | +7

6

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac : a multicentre, open-label, phase 4, randomised trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Tang, R. | Zheng, H. | Wang, B. | +24

7

Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies : a systematic review and meta-analysis of randomised controlled trials

enthalten in: The Lancet. Microbe | 2023

von Yang, Z. | Jiang, Y. | Li, F. | +12

8

Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults : a randomized, double-blinded, immunobridging trial

enthalten in: Expert review of vaccines | 2023

von Wu, Y. | Wei, M. | Wang, R. | +11

9

A China-developed adenovirus vector-based COVID-19 vaccine : review of the development and application of Ad5-nCov

enthalten in: Expert review of vaccines | 2023

von Wang, S. | Liu, W. | Li, Y. | +2

10

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis : a systematic review and meta-analysis

enthalten in: Human vaccines & immunotherapeutics | 2022

von Wang, S. | Sun, J. | Liu, P. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]